Which pharmaceutical pricing strategy innovation from the early 2000s dramatically improved HIV/AIDS medication access in developing countries?

Pricing strategies in the pharmaceutical industry have evolved dramatically over the past few decades, influenced by research costs, regulatory environments, and market dynamics. This poll tests your knowledge about a landmark pricing strategy shift that changed how life-saving medications are accessed in developing countries. Understanding historical pricing strategies helps contextualize current debates around drug pricing and accessibility in global medicine.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Tiered pricing models based on country GDP
Subscription-based medication access programs
Blockchain-verified pricing transparency
Dynamic pricing based on seasonal disease prevalence